Latest Articles

Publication Date
All News Scientific
Endometrial Cancer Market Diagnosing and Treating a Growing - openPR

Endometrial Cancer Market Diagnosing and Treating a Growing openPR

Published: Dec. 11, 2024, 10:11 a.m.
Read Full Article
Dermatologist Warns: Laptops And Heating Pads May Cause Permanent Skin Damage; Know About Toasted Skin Syndrome - Medical Daily

Dermatologist Warns: Laptops And Heating Pads May Cause Permanent Skin Damage; Know About Toasted Skin Syndrome Medical Daily

Published: Dec. 11, 2024, 6:20 a.m.
Read Full Article
Expert Shares 5 Ways To Know If Your Menstrual Cramps Have Advanced Towards Endometriosis - Onlymyhealth

Expert Shares 5 Ways To Know If Your Menstrual Cramps Have Advanced Towards Endometriosis Onlymyhealth

Published: Dec. 11, 2024, 6:07 a.m.
Read Full Article
An Unusual Case of Pelvic Congestion Syndrome: A Case Report - Cureus

An Unusual Case of Pelvic Congestion Syndrome: A Case Report Cureus

Published: Dec. 11, 2024, 4:33 a.m.
Read Full Article
Female-Specific Factors Don’t Enhance Common Risk Calculators - TCTMD

Female-Specific Factors Don’t Enhance Common Risk Calculators TCTMD

Published: Dec. 10, 2024, 9 p.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - BioSpace

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer BioSpace

Published: Dec. 10, 2024, 12:23 p.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - Yahoo Finance

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer Yahoo Finance

Published: Dec. 10, 2024, 11 a.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - PR Newswire

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer PR Newswire

Published: Dec. 10, 2024, 11 a.m.
Read Full Article
Women in the UK: share your experience of gynaecological pain - The Guardian

Women in the UK: share your experience of gynaecological pain The Guardian

Published: Dec. 10, 2024, 10:49 a.m.
Read Full Article
Women in the UK: share your experience of gynaecological pain - Inkl

Women in the UK: share your experience of gynaecological pain Inkl

Published: Dec. 10, 2024, 10:46 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!